Harvard Bioscience Inc (HBIO) Growth Rates Comparisons to Laboratory Analytical Instruments Industry, Sector, Market. Sales, Income, EPS
CSIMarket Company Name, Ticker, Customers, else..
 
Harvard Bioscience Inc   (NASDAQ: HBIO)
 

Harvard Bioscience Inc Growth Comparisons

Select each growth Category to receive further Information




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

HBIO Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q1 MRQ) -4.44 % 10.91 % 12.44 % 10.9 %
Q / Q Revenue Growth (Q1 MRQ) -19.58 % -3.61 % -5.89 % 8.32 %
Y / Y Revenue Growth (for 12 months ending Q1 TTM) -6.81 % 3.8 % 8.03 % %
Sequential Revenue Growth (for 12 months ending Q1 TTM) -1.09 % 2.54 % 2.11 % 2.61 %
Revenue 5 Year Average Growth -3.39 % 3.1 % 9.34 % 13.48 %


HBIO's Growth Comparisons in I. Quarter 2026




Although the Laboratory Analytical Instruments industry saw advancing Revenue by 10.91%, Harvard Bioscience Inc announced -4.44% year on year sales decline in the first quarter 2026, to $ 20 millions, and underperformed the 12.44% Revenue improvement in the Healthcare sector. Although both Laboratory Analytical Instruments industry and Healthcare sector posted higher gains than 10.9% overall market increase, Harvard Bioscience Inc was trailing overall market in the first quarter.

Comparing company's Revenue to the fourth quarter results, sales were lower by -19.58% . On the annual basis, average annual sales growth for Harvard Bioscience Inc is -3.39%, while S & P 500's including only Businesses with the first quarter 2026 results, average yearly sales growth is 13.48% over the past five years.

HBIO Growth Rates by Company's Segments

Segment Name
Y / Y
Sequential
Transferred at Point in Time
-7.21 %
-
Transferred over Time
59.23 %
-
Instruments Equipment Software and Accessories
-6.54 %
-
Service Maintenance and Warranty Contracts
8.33 %
-
UNITED STATES
-10.4 %
-
Americas Other
2.17 %
-
EMEA
7.31 %
-
CHINA
2.67 %
-
Asia Other
-22.47 %
-
Installation and Training
45.12 %
-
Customer Advances
-36.9 %
-
Total
-4.44 %
-76.44 %


Growth Rates of HBIO's Income in the first quarter 2026


HBIO Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q1 MRQ) - 67.67 % 4.02 % 97.6 %
Sequential Operating Income Change (Q1 MRQ) - -28.55 % 0.66 % 48.13 %
Y / Y Operating Income Growth (Q1 TTM) - 9.27 % 25.18 % 40.67 %
Sequential Operating Income Growth (Q1 TTM) - 10.32 % -0.33 % 20.86 %
Operating Income 5 Year Avg. Change - -6.57 % 10.62 % 28.66 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q1 MRQ) - - -27.62 % 90.69 %
Sequential Income from Cont. Ops. Change (Q1 MRQ) - - -67.3 % 27.07 %
Y / Y Income from Cont. Ops. Change (Q1 TTM) - - 1.91 % 57.33 %
Sequential Income from Cont. Ops. Change (Q1 TTM) - -7.36 % -5.38 % 18.65 %
Income from Cont. Ops. 5 Year Avg. Change - -16.43 % 8.95 % -24.17 %

HBIO Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q1 MRQ) - -37.36 % -27.58 % 90.69 %
Q / Q Net Income Growth (Q1 MRQ) - -93.87 % -2.01 % 27.07 %
Y / Y Net Income Change (Q1 TTM) - - 13.54 % 57.33 %
Sequential Net Income Change (Q1 TTM) - -2.4 % -7.44 % 18.65 %
Net Income 5 Year Avg. Growth - -16.48 % 9.41 % 30.75 %

HBIO's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q1 MRQ) - - -27.62 % 90.69 %
Sequential EPS from Cont. Ops. Change (Q1 MRQ) - - -67.3 % 27.07 %
Y / Y EPS from Cont. Ops. Change (Q1 TTM) - - - -
Sequential EPS from Cont. Ops. Change (Q1 TTM) - -56.1 % - 4.88 %
EPS from Cont. Ops. 5 Year Avg. Growth - -21.88 % 8.95 % -24.17 %



HBIO EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q1 MRQ) - -38.22 % -27.58 % -24.17 %
Q / Q EPS Net Growth (Q1 MRQ) - -93.96 % -2.01 % 27.07 %
Y / Y EPS Net Change (for 12 months ending Q1 TTM) - - - 7.62 %
Sequential EPS Net Change (for 12 months ending Q1 TTM) - -56.06 % - 4.93 %
EPS Net 5 Year Avg. Change - -16.48 % 9.41 % 30.75 %



Harvard Bioscience Inc reported bottom-line of $ -0.77 in the first quarter, compare to $ -11.42 in the same quarter a year ago. Laboratory Analytical Instruments industry fell by -38.22%, while Healthcare sector decreased by -27.58%, and overall market improved by 90.69%.

Comparing the company's EPS to the fourth quarter results, income per share were lower by -19.58% . On the annual basis, average annual income per share growth for Harvard Bioscience Inc is -3.39%, while S & P 500's including only Businesses with the first quarter 2026 financial reports, average yearly income per share growth is 30.75% over the past five years.

HBIO Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q1 MRQ) - -38.71 % 56.23 % 48.62 %
Sequential Free Cash Flow Change (Q1 MRQ) - -56.03 % -49.65 % 34.18 %
Y / Y Free Cash Flow Change (Q1 TTM) - -17.54 % 23.5 % 60.27 %
Sequential Free Cash Flow Change (Q1 TTM) -73.67 % -8.27 % 6.14 % 15.75 %
Free Cash Flow 5 Year Avg. Change -9.86 % -2.7 % 1.82 % 18.38 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q1 MRQ) - - - 339.02 %
Sequential Net Cash Flow Change (Q1 MRQ) - - - 216.68 %
Y / Y Net Cash Flow Change (Q1 TTM) 20.22 % - - 209.43 %
Sequential Net Cash Flow Change (Q1 TTM) - -86.26 % -93.98 % 152.64 %
Net Cash Flow 5 Year Avg. Change - 16.21 % 6.07 % 4.29 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q1 MRQ) -9.22 % -5.56 % 8.1 % 120.03 %
Sequential Capital Expenditures Change (Q1 MRQ) 3.51 % -18.49 % -19.56 % 36.87 %
Y / Y Capital Expenditures Change (Q1 TTM) -44.2 % -5.65 % 6.72 % 109.38 %
Sequential Capital Expenditures Change (Q1 TTM) -3.38 % -1.57 % 1.66 % 23.05 %
Capital Expenditures 5 Year Avg. Change - 5.15 % 7.09 % 10.56 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.